Clinics and research in hepatology and gastroenterology · 2025
Trends, disparities, and outcomes of drug-induced pancreatitis in the United States: A nationwide analysis (2016-2020).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tchoukeu Guy Loic Nguefang, Boateng Sarpong, Mekontso Joel Gabin Konlack, Al-Ajlouni Yazan A, Njei Basile
Аннотация
BACKGROUND: Drug-induced pancreatitis (DIP) is an underreported etiology of acute pancreatitis. DIP risk and prevalence has increased over the years with polypharmacy. Data on affected patients in the U.S. remain limited. We aim to assess disparities and outcomes in DIP hospitalizations.
METHODS: Retrospective study including adults diagnosed with DIP using the National Inpatient Sample (NIS) database (2016-2020). The primary outcomes were inpatient mortality, and complications. Secondary outcomes included resource utilization metrics. Descriptive statistics, linear regression, and logistic regression were performed using SAS 9.4.
RESULTS: 5666 patients (mean age: 56.5 years; females 53.6 %) were included. Common comorbidities were hypertension (61.3 %), hyperlipidemia (42.3 %), and diabetes (22.9 %). The mortality rate was 1.5 %, with acute kidney injury (20.6 %), Sepsis (5.0 %), ileus (3.5 %) the common complications. The Mean LOS was 5.5 days, and the mean hospital charges were $60,811.20. Compared to White, Hispanics had significant odds of DIP admission (aOR: 1.11, 95 % CI: 1.01-1.21, p = 0.03) and increased risk of cardiac arrest (aOR 4.34, 95 % CI 1.17-15.35, p = 0.02). Black patients had significantly higher odds of severe DIP (aOR 1.26, 95 % CI 1.02-1.56, p = 0.03) and acute kidney injury (aOR 1.29, 95 % CI 1.04-1.61, p = 0.02), while Asian were more likely to develop sepsis (aOR 2.10, 95 % CI 1.07-3.83, p = 0.02), had higher hospital charges (+$42,008, p = 0.039) and longer LOS (+2.5 days, p < 0.01)..
CONCLUSION: There are significant racial disparities among patients and a substantial economic burden on healthcare systems. Multifaceted strategies and research into genetic and socioeconomic predispositions are needed to address DIP.
METHODS: Retrospective study including adults diagnosed with DIP using the National Inpatient Sample (NIS) database (2016-2020). The primary outcomes were inpatient mortality, and complications. Secondary outcomes included resource utilization metrics. Descriptive statistics, linear regression, and logistic regression were performed using SAS 9.4.
RESULTS: 5666 patients (mean age: 56.5 years; females 53.6 %) were included. Common comorbidities were hypertension (61.3 %), hyperlipidemia (42.3 %), and diabetes (22.9 %). The mortality rate was 1.5 %, with acute kidney injury (20.6 %), Sepsis (5.0 %), ileus (3.5 %) the common complications. The Mean LOS was 5.5 days, and the mean hospital charges were $60,811.20. Compared to White, Hispanics had significant odds of DIP admission (aOR: 1.11, 95 % CI: 1.01-1.21, p = 0.03) and increased risk of cardiac arrest (aOR 4.34, 95 % CI 1.17-15.35, p = 0.02). Black patients had significantly higher odds of severe DIP (aOR 1.26, 95 % CI 1.02-1.56, p = 0.03) and acute kidney injury (aOR 1.29, 95 % CI 1.04-1.61, p = 0.02), while Asian were more likely to develop sepsis (aOR 2.10, 95 % CI 1.07-3.83, p = 0.02), had higher hospital charges (+$42,008, p = 0.039) and longer LOS (+2.5 days, p < 0.01)..
CONCLUSION: There are significant racial disparities among patients and a substantial economic burden on healthcare systems. Multifaceted strategies and research into genetic and socioeconomic predispositions are needed to address DIP.